EDINBURGH, Scotland, Aug. 28, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC (TCBP) ("TC BioPharm" or the "Company") a clinical stage biotechnology company developing platform allogeneic gamma-delta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback